Introduction

ALP is a zinc-containing glycoprotein that catalyzes the hydrolysis of phosphate monoesters at alkaline conditions. It is an important enzyme that participates in cellular phosphorus metabolism, thus has been regarded as a biomarker for the diagnosis of a series of diseases. The abnormally increased concentration level of ALP in human serum is related to liver and bone diseases[1, 2]. Also, the lowered concentration level of ALP commonly indicates malnutrition. To further understand the role of ALP, especially on the single-cellular levels, there is a high demand for developing precise and sensitive assays to quantify ALP.

In recent years, various colorimetric [3,4,5,6], fluorescent [7,8,9,10,11], chemiluminescent [12,13,14], electrochemiluminescent [15], and electrochemical [16, 17] detection systems had been established for the detection of ALP in serum, tissues, and cell lysates. Among these methods, the CL analytical method was featured as high sensitivity, wide linear range, and simple instrument. In recent years, L-ascorbic acid 2-phosphate trisodium salt (AAP) and MAP were reported as the substrates for the CL detection of ALP activity [18, 19]. The hydrolysis of AAP or MAP by ALP produces ascorbic acid which is commonly considered as a quencher to the luminol CL reaction. Based on the quenched CL signal, several turn-off CL sensing methods were established to detect the activity of ALP. For example, Huang’s group established a luminol–H2O2–K2S2O8 CL system with long life and high-intensity emission. Based on the quenching effect of ascorbic acid on the CL signal, a CL assay for the detection of ALP was developed using AAP as the substrate [20]. Similarly, Fan’s group employed MAP as the enzymatic substrate of ALP. The hydrolysis product, ascorbic acid, quenched the gold nanoclusters-catalyzed luminol–H2O2 CL reaction, based on which a CL assay for the detection of ALP in human serum was developed [19]. These turn-off CL sensing methods suffered from a high background which was hard to observe the signals produced from low concentrations of ALP.

Here, we would like to report a turn-on CL sensing platform based on Fe-centered MOFs for the detection of ALP activity using MAP as the substrate. MOFs are formed by connecting metal units with organic ligands through coordination bonds. As signal probes, MOFs have received special attention in ALP detection because they have multiple active sites, large specific surface areas, and designable structures [21, 22]. Such as Tan’s group employed sodium tripolyphosphate as the substrate of ALP and established a photoelectrochemical assay for the detection of ALP based on controllable sensitization of Zr-MOFs (UiO-66) with Cds quantum dots [23]. Lin’s group developed a fluorescent sensing platform for the detection of ALP using pyrophosphate (PPi) as the substrate the hydrolysis product of which inhibited the fluorescent signals of o-phenylenediamine (OPD) oxidized by NH2–Cu-MOFs. In the CL analysis field, Du’s group designed a label-free chemiluminescent resonance energy transfer (CRET) platform for the detection of ALP using adenosine 5′-monophosphate (5′-AMP) as the substrate and Tb@Zn–MOFs as the signaling probe. The hydrolysis of 5′-AMP by ALP produced PO43– ions that reacted with Tb3+ ions to form Tb-PO43– resulting in a low CRET efficiency and a decrease in the CL signal [24].

Metal organic framework nanosheets are a new member of ultrathin 2D nanomaterials that combine the advantages of 2D nanomaterials with MOF crystals. As a canonical type of metal organic framework nanosheet, 2D Fe-BTC was built by connecting ferric ions and benzene tricarboxylic acid linkers [6, 25, 26]. To the best of our knowledge, the employment of 2D Fe-BTC as the signaling probe for the detection of ALP has not been reported yet. In the present study, the enhancement effect of ascorbic acid on the luminol–Fe-BTC system was discovered for the first time, which provided us with a good opportunity to develop a turn-on CL assay for the detection of ALP by using MAP as the enzyme substrate. The turn-on CL assay has the advantage of low background, thus, achieving sensitive and precise detection of ALP.

Experiment

Chemicals

Polyvinylpyrrolidone (PVP), alkaline phosphatase (from calf intestinal, 2000 U mg−1), α-glucosidase (from Saccharomyces, 33 U mg−1), cysteine, and arginine were provided by Yuanye Bio-Technology Co., Ltd. (Shanghai China). MAP was purchased from Dibai Bio-Technology Co., Ltd. (Shanghai, China). H3BTC and glutathione (GSH) were purchased from Heowns Biochemical Technology Co, Ltd. (Tianjin, China). β-d glucose was obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Methanol, ferric chloride hexahydrate (FeCl3·6H2O), copper chloride dihydrate (CuCl2·2H2O), magnesium chloride hexahydrate (MgCl2·6H2O), Ferrous chloride tetrahydrate (FeCl2·4H2O) and tris(hydroxymethyl)aminomethane (Tris) were obtained from Jiangtian Chemical Co., Ltd. (Tianjin, China). Luminol was purchased from Alfa Aesar. Bovine serum albumin (BSA) and uric acid were obtained from Sigma-Aldrich. L-Ascorbic acid was obtained from Kermel Chemical Reagent Co., Ltd. (Tianjin, China). Human serum was obtained from Puboxin Bio-Technology Co., Ltd. (Beijing, China). ALP activity assay kit for the determination of ALP in serum samples was purchased from Boxbio Science and Technology Co., Ltd. (Beijing, China). Ultrapure water (18.24 MΩ) purified by an ultrapure water purification system of Youpu Co., Ltd. (Sichuan, China) was used in all experiments.

The 20× hydrolysis buffer solution was prepared by dissolving 24.2 mg of Tris, 14.92 g of KCl, and 4 mg of Triton X-100 in 100 mL of volumetric flasks and then made up to the scale with water.

The hydrolysis buffer solution was 1 × hydrolysis buffer containing 0.2 mg mL−1 of BSA and 5 mM MgCl2.

Apparatus

CL emission spectra were detected by a BPCL chemiluminescence analyzer purchased from Microphotonics Technologies Co., Ltd. (Guangzhou, China). The BPCL chemiluminescence analyzer was equipped with a series of high-energy optical filters of 320, 350, 380, 400, 425, 440, 460, 490, 535, 555, and 575 nm. CL intensity measurements were performed on Fluoroskan Ascent FL microplate reader (Thermo Scientific, US). Transmission electron microscopic (TEM) images were recorded on a high-resolution transmission electron microscope (FEI Tecnai G2 F20, US). Fourier transformation infrared (FT-IR) spectra were recorded on a Tensor 27 FT-IR spectrophotometer (Bruker, Germany). The X-ray photoelectron spectra (XPS) were determined on ThermoFisher Escalab 250Xi (Thermal Electron, US).

Synthesis of 2D Fe-BTC

2D Fe-BTC MOF was synthesized according to previous reports [26]. Firstly, Cu2O was synthesized by mixing 0.0134 g CuCl2 and 0.1 g PVP in 40 mL of water. Then, 2.5 mL of 100 mM ascorbic acid and 2.5 mL of 200 mM NaOH were added to the mixture slowly. The reaction solution was kept stirring at room temperature for 0.5 h. The product was separated by centrifugation at 10,000 rpm for 6 min and washed three times with ethanol. The Cu2O was dispersed in 10 mL of ethanol and used to prepare Cu-BTC. To prepare Cu-BTC, 10 mL of Cu2O was mixed with 4 mL 50 mg mL−1 H3BTC and 400 mg PVP K30 dissolved in 60 mL of water. After stirring at room temperature for 16 h, a blue precipitate was obtained after centrifugation at 10,000 rpm for 16 min. The blue precipitate was washed twice with ethanol and water, respectively. Then, the product was vacuum-dried overnight at 60 oC. Finally, the 2D Fe-BTC was synthesized by substituting the Cu2+ ions in Cu-BTC with Fe3+ ions. Briefly, 10 mg of Cu-BTC was dispersed in 10 mL of water and mixed with 10 mL of 3 mg mL−1 FeCl3, the mixture of which was stirred at room temperature for 3 h. The color of the reaction solution changed from blue to yellow indicating the formation of 2D Fe-BTC. The final product was obtained by centrifugation at 10,000 rpm for 10 min and washed twice with ethanol and water, respectively. The product was vacuum-dried overnight under 60 oC. The stock solution of 2D Fe-BTC was prepared by dispersing Fe-BTC ultrapure water with a concentration of 1 mg mL−1.

CL detection of ascorbic acid

For the CL detection of ascorbic acid, 50 μL of different concentrations of ascorbic acid prepared in ultrapure water was mixed with 50 μL of 10 μg mL−1 Fe-BTC suspension in the well of a 96-well plate and incubated at room temperature for 5 min. Then, 100 μL of 2 mM luminol in 0.1 M Tris–HCl buffer solution (pH 9) was injected into the well by a dispenser. The CL intensity was monitored by the Fluoroskan Ascent FL microplate reader. Each sample was detected three times parallelly.

CL detection of ALP

For the CL detection of ALP, 20 μL of 100 μM MAP was mixed with 180 μL of ALP with different concentrations in a hydrolysis buffer and incubated at 37 °C for 60 min. 50 μL of the resultant solution was mixed with 50 μL of 10 μg mL−1 Fe-BTC in the well of a 96-well plate. The following steps were the same as described above.

Results and discussion

Effect of ascorbic acid on luminol–Fe-BTC CL reaction

Ascorbic acid as a broad-spectrum scavenger for oxygen-related species is commonly considered to be a quencher in the luminol CL reaction and has been employed to study the mechanism of luminol CL reactions [27]. However, an interesting phenomenon we found was that a strong CL emission was observed when the luminol solution was injected into the mixture of 2D Fe-BTC and ascorbic acid. As shown in Fig. 1a, when 100 μL of 2 mM luminol was injected into the mixture of 2D Fe-BTC (100 µg mL−1) and ascorbic acid (1 μM), a flash-type CL signal was observed. The CL signal reached the maximum after 0.3 s of injecting luminol into the mixture. In contrast, when the luminol solution was injected into 100 µg mL−1 Fe-BTC or 1 μM ascorbic acid respectively, very weak CL signals were produced. The result demonstrated that the 2D Fe-BTC or ascorbic acid alone had no enhancement effect in the luminol CL reaction. However, when the 2D Fe-BTC was mixed with ascorbic acid, an about 30-fold enhanced CL signal was observed. What's more, the CL intensity of the luminol CL reaction increased by prolonging the incubation time of Fe-BTC with ascorbic acid (Fig. 1b). We speculated that the incubation of Fe-BTC with ascorbic acid may generate a product catalyzing the luminol CL reaction even without any additional oxidants.

Fig. 1
figure 1

a The CL kinetic curves and b the influence of incubation time on the CL reaction. Experimental conditions: 10 μM ascorbic acid, 1 mM luminol in 0.1 M Tris–HCl buffer solution (pH 10), 100 μg mL−1 Fe-BTC

To verify our hypothesis, the UV–Vis spectra of each reactant and their mixtures were recorded first (Fig. 2a). The characteristic absorption bands of luminol are located at 224 nm, 300 nm, and 345 nm, respectively. After the CL reaction, the absorption bands at 224 nm and 300 nm moved to 230 nm and 290 nm which indicated the transformation of phthalic hydrazide to phthalate ions. The maximum absorption wavelength of ascorbic acid was located at 265 nm while Fe-BTC showed terminal adsorption around 210 nm. The incubation of ascorbic acid with the 2D Fe-BTC resulted in the disappearance of the absorption peak of ascorbic acid located at 265 nm suggesting that ascorbic acid may be oxidized by the Fe-BTC. Then, the FT-IR spectra of the 2D Fe-BTC before and after the CL reaction were determined. As shown in Fig. 2b, the FT-IR spectra for both cases exhibited a similar profile. The characteristic absorption bands located at 1621 cm−1, 1568 cm−1, 1441 cm−1, 1375 cm−1, 760 cm−1 and 710 cm−1 were ascribed to benzene tricarboxylic acid in Fe-BTC. This result indicated that the ligand (BTC) didn’t take part in the redox reaction with ascorbic acid. Besides, the Fe-BTC after the CL reaction also showed an absorption band at 472 cm−1 which was correlated with the stretching vibration of (Fe–O) in Fe-BTC suggesting that the chelating of iron ions with ligands still existed. To investigate the valent state of iron ions in Fe-BTC after the CL reaction, the XPS of the Fe-BTC before and after the CL reaction were determined. Figure 2c is the high-resolution spectra of Fe 2p of Fe-BTC before the CL reaction. The Fe-BTC without incubation with ascorbic acid exhibited two characteristic peaks at 711.7 and 725.5 eV, respectively, which were attributed to Fe 2p3/2 and Fe 2p1/2. After incubating with ascorbic acid, the Fe-BTC exhibited two broadened peaks at 711.9 and 725.7 eV. (Fig. 2d). This discrepancy was ascribed to the formation of Fe2+. The peaks at 711.2 and 724.2 eV were assigned to Fe2+. The XPS spectra suggested that the incubation of the 2D Fe-BTC with ascorbic acid resulted in the reduction of Fe3+ to Fe2+ ions. To verify the generation of Fe2+, 1,10-phenanthroline that reacts with Fe2+ to produce a coordination complex having a maximum absorption at 510 nm was employed. 100 μg mL −1 of Fe-BTC was incubated with 500 μM ascorbic acid at room temperature for 20 min, to which 50 μL of 60 mg L−1 1,10-phenanthroline was then added. Consistent with our hypothesis, the reaction product showed maximum absorption at 510 nm (Fig. S1). The results suggested that the incubation of Fe-BTC with ascorbic acid led to the reduction of Fe3+ ions in 2D Fe-BTC to Fe2+ ions. The reduced Fe-BTC was a efficient catalyst in the luminol CL reaction that catalyzed the oxidation of luminol to emit light even without addional oxidants. Besides, the TEM images of the 2D Fe-BTC before and after the CL reaction were determined. Before the CL reaction, the 2D Fe-BTC had a transverse size of 5 μm (Fig. 2e). After incubating with ascorbic acid, the structure of 2D Fe-BTC was still maintained (Fig. 2f).

Fig. 2
figure 2

a UV–Vis spectra of each reactant and their mixtures. b FT-IR spectra of 2D Fe-BTC incubated with and without ascorbic acid. c, d XPS spectra of Fe 2p peaks and e, f TEM images of the 2D Fe-BTC incubated without (c, e) or with (d, f) ascorbic acid

CL mechanism studies

The CL emission spectra were determined on the BPCL analyzer equipped with a series of light filters. Figure 3 is the CL spectra of the CL reaction with and without the addition of ascorbic acid, respectively. When 2 mM luminol was injected into 100 μL of 50 μg mL−1 2D Fe-BTC directly, a weak CL emission located at 425 nm was observed. In the case of incubating the 2D Fe-BTC with 10 μM ascorbic acid, an enhanced CL emission at 425 nm was obtained. The maximum emission wavelength at 425 nm suggested the luminophores of both cases were still 3-aminophthalate anions in excited states (3-APA*).

Fig. 3
figure 3

CL spectra of the CL reaction with and without the addition of ascorbic acid. Experimental conditions: 2 mM luminol in 0.1 M Tris–HCl buffer solution (pH 9), 50 μg mL−1 Fe-BTC

Because there is no additional oxidant added to the CL reaction, the dissolved oxygen was considered as one of the oxidants to oxidize luminol to produce the 3-APA*. To explore the role of dissolved oxygen in the CL reaction, the CL signal was determined after bubbling all of the CL reaction solutions with gas N2 for 30 min to remove dissolved O2. The CL intensity decreased by 14.6% proving that dissolved oxygen participated in the CL reaction. Besides, H2O2 which was produced from the redox reaction of the 2D Fe-BTC with ascorbic acid may be the other oxidant in the CL reaction[28]. Then, to explore the types of oxygen-related free radicals involving in the CL reaction, different kinds of free-radical scavengers were added to the CL solution. The CL intensity decreased by 67.3%, 57.5%, and 94.2% in the presence of 5% methanol, 10 U of superoxide dismutase (SOD), and 0.5 mM histidine, respectively. The results suggested that hydroxyl radicals (·OH), superoxide anion radical (O2▪−), and singlet oxygen (1O2) were involved in the luminol–Fe-BTC-ascorbic acid CL reaction. The possible mechanism was summarized in Scheme 1. The 2D Fe-BTC reacted with ascorbic acid producing reduced Fe-BTC and H2O2. The reduced Fe-BTC that has Fe2+ ions may undergo a classical Fenton reaction with H2O2 to generate ·OH which oxidized luminol anions to form luminol radicals. Also, the reduced Fe-BTC may react with dissolved O2 to form Fe-BTC and O2⋅−. The Haber–Weiss reaction may occur between O2⋅− and H2O2 to produce ·OH and 1O2. Besides, 1O2 may also be produced from the reaction of ·OH and O2⋅−. Finally, the luminol radicals were oxidized by these oxygen-related species including ·OH, O2⋅−, and 1O2 to produce the excited-state 3-APA* that emits blue light at 425 nm.

Scheme 1
scheme 1

The possible mechanism of the luminol-Fe-BTC-ascorbic acid CL system

Optimization of CL conditions

The reaction conditions including the pH of the reaction, the concentration of luminol and 2D Fe-BTC were optimized systematically by fixing the incubation time of Fe-BTC with ascorbic acid at 5 min. 0.1 M Tris–HCl buffer solution was employed to prepare the working solution of luminol and to maintain the pH of the CL reaction. As shown in Fig. 4a, a higher pH condition resulted in a stronger blank signal and a lower S/N ratio which referred to the signal ratio of the sample test to that of the blank test. Thus, the pH of the Tris–HCl buffer solution was set at pH 9. Figure 4b is the influence of the concentration of 2D Fe-BTC on the CL reaction. Both of sample signal and blank signal increased with higher concentrations of 2D Fe-BTC. Although the highest S/N ratio was obtained by using 1 μg mL−1 of Fe-BTC, the CL intensity at this data point was relatively low. Thus, 10 μg mL−1 of Fe-BTC was selected for the following studies. A higher concentration of luminol is a benefit to the CL reaction. The CL intensity of sample tests increased dramatically with an increased concentration of luminol without a significant enhancement on the blank signals (Fig. 4c). The S/N ratio increased linearly with the increased concentration of luminol ranging from 0.2 to 3 mM. Considering the reagent consumption, 2 mM luminol was employed in the following studies. In summary, experimental conditions including Tris–HCl buffer with pH 9, 2 mM luminol, 10 μg mL−1 of Fe-BTC, and 5 min of incubation time were employed in the following studies.

Fig. 4
figure 4

Optimization of experimental conditions including a pH of the buffer solution, the concentration of b Fe-BTC, and c luminol. Experimental conditions: a 1 μM ascorbic acid, 1 mM luminol in 0.1 M Tris–HCl buffer solution with different pH values, 100 μg mL−1 Fe-BTC. b pH 9 of 0.1 M Tris–HCl buffer solution, other experimental conditions were the same as (a). c 10 μg mL−1 Fe-BTC, other experimental conditions were the same as (b)

CL responses for ascorbic acid

To test the CL response of the luminol CL reaction to different concentrations of ascorbic acid, different concentrations of ascorbic acid were prepared in ultrapure water and mixed with 10 μg mL−1 Fe-BTC, respectively. After the injection of luminol solution into the mixture, the CL intensity was determined. As shown in Fig. 5, as the concentration of ascorbic acid increased from 5 to 500 nM, the CL intensity increased linearly with increasing concentration of ascorbic acid. The regression equation was described as I = 0.00572C + 0.05943 (R2 = 0.9936). The limit of detection (LOD) for ascorbic acid was calculated to be 0.5 nM (3 δ/s). To test the repeatability of the CL reaction, two concentrations of ascorbic acid (100 and 10 nM) were determined six times under the optimized CL conditions, and the relative standard deviation (RSD) for 100 and 10 nM ascorbic acid was 0.72% and 2.83%, respectively.

Fig. 5
figure 5

Response curve of the luminol-Fe-BTC system with different concentrations of ascorbic acid

Principle of CL detection of ALP

In light of the high sensitivity of the luminol-Fe-BTC CL system for the detection of ascorbic acid, the proposed CL reaction was then applied to the detection of ALP using MAP as the substrate. MAP is phosphorylated ascorbic acid, which is more stable than ascorbic acid even after treatment at a high temperature [29]. MAP can be hydrolyzed by ALP to produce ascorbic acid and magnesium phosphate under an alkaline condition. The detection principle as shown in Scheme 2, the produced ascorbic acid then reacts with 2D Fe-BTC producing reduced Fe-BTC which catalyzes the luminol CL reaction. With the concentration of ALP increased, increasing concentrations of ascorbic acid are produced resulting in higher CL signals, thus, achieving the quantitative detection of ALP.

Scheme 2
scheme 2

Schematic diagram of the turn-on CL assay for the detection of ALP

To verify the feasibility of the method, the CL responses of the luminol CL reaction to different concentrations of ascorbic acid in hydrolysis buffer were determined firstly. Here, different concentrations of ascorbic acid were prepared with the hydrolysis buffer solution (pH 8.5) instead of ultrapure water. The results were shown in Fig. S2 (Supporting Information). Although the CL signals of the luminol CL reaction produced by ascorbic acid in the alkaline hydrolysis buffer were lower than that prepared in ultrapure water, the CL intensity increased linearly with increasing concentration of ascorbic acid. The detection linear range was from 20 to 500 nM, and the LOD was calculated to be 13.7 nM (3 δ/s). The regression equation was described as I = 0.0009C + 0.0435 (R2 = 0.9829). Besides, the CL signals of the luminol–Fe-BTC CL system in the presence of ALP, MAP, and both of them were determined. As shown in Fig. 6, when 100 µM MAP was incubated with 0.5 U L−1 ALP and then 10 µg mL−1 Fe-BTC, after injecting 2 mM luminol into the reaction solution, a strong CL signal was observed. However, if MAP or ALP alone was incubated with the 2D Fe–BTC, very weak CL signals were obtained. The results demonstrated that MAP could be employed as the substrate for the development of a turn-on CL assay for ALP by coupling the enzymatic reaction with the luminol-Fe-BTC CL reaction.

Fig. 6
figure 6

The CL kinetic curves of the luminol-Fe-BTC CL system with the addition of MAP, ALP, and both of them. Experimental conditions: 100 μM MAP, 0.5 U L−1 ALP, 2 mM luminol in 0.1 M Tris–HCl buffer solution (pH 9), 10 μg mL−1 Fe-BTC

CL detection of ALP

To establish the CL assay for ALP, the influence of experimental conditions such as the concentration of MAP and incubation time of MAP with ALP on the CL detection of ALP were explored (Fig. S3, Supporting Information). When the concentration of MAP was 100 μM and the incubation time was 60 min, the S/N ratio was the highest. To evaluate the capability of the CL method for the quantitative detection of ALP, increasing concentrations of ALP were incubated with 100 μM MAP at 37 °C for 60 min and then mixed with 10 µg mL−1 Fe-BTC. After injecting the working solution of luminol into the mixture, the CL intensity was determined. As shown in Fig. 7a, the CL intensity increased linearly with the concentration of ALP in the range of 0.001–0.1 U L−1. The standard curve for CL detection of ALP was described as I = 5.0589C + 0.0159 (R2 = 0.9955). The LOD for ALP was 0.00046 U L−1. Compared with previously reported methods, the proposed CL assay showed good sensitivity as well as a wide linear range (Table 1). 0.1 U L−1 ALP was determined 6 times and the RSD was 3.9% indicating the good repeatability of the ascorbic acid-enhanced luminol-Fe-BTC CL system for the detection of ALP. The proposed CL assay for the detection of ALP is based on the hydrolysis of MAP to produce ascorbic acid which has an enhancement effect in the luminol-Fe-BTC CL reaction. Thus, as shown in Fig. 7b, the CL system had no response to other substances including metal ions (such as Na+, Cu2+, and Mn2+), amino acids (such as Arg), and other kinds of enzymes (such as α-glucosidase), proteins (such as streptavidin and IgG) and reducing substances (such as GSH, cysteine, glucose, and uric acid). The good selectivity was attributed to the specific hydrolysis ability of ALP to MAP which produced ascorbic acid and the specific CL response of the luminol-Fe-BTC system to ascorbic acid.

Fig. 7
figure 7

a Standard curve for the CL detection of ALP. b The specificity of the luminol-Fe-BTC-MAP for the ALP detection. Experimental conditions were the same as in Fig. 6

Table 1 Comparison of our method with other ALP detection methods

Detection of ALP in serum samples

Serum samples contain lots of substances that may affect the CL detection of ALP. To evaluate the matrix effect of serum samples on the CL detection of ALP. A commercially available serum sample was employed and pretreated at 75 °C for 10 min to inactivate ALP in the serum. Then, the deactivated serum samples were diluted at different times with the hydrolysis buffer solution and then spiked with 0.01 U L−1 ALP. The CL signals were determined under optimal conditions. The results were shown in Fig. S4 (Supporting Information), the CL intensities of ALP in 100, 500, 1000, and 2000-fold diluted serum samples were significantly decreased compared with the CL signal of ALP in hydrolysis buffer solution. We assumed that the proteins in the serum may combine with the metal ions of Fe-BTC, thus preventing the reduction of Fe3+ by ascorbic acid. When the serum was diluted 5000 times, 0.01 U L−1 ALP produced a CL signal that is similar to that produced in the hydrolysis buffer solution. Considering the concentration of ALP in normal human serum is from 70 to 90 U L−1 [30], theoretically, the content of ALP in 5000-fold diluted serum sample ranges from 0.014 to 0.018 U L−1 which is within the detection linear range of the proposed CL assay. Thus, the 5000-fold diluted serum sample was selected and a standard addition method was employed to evaluate the accuracy of the proposed CL method for the detection of ALP in serum samples. Three concentrations of ALP (50, 100, and 150 U L−1) were spiked into the ALP-deactivated human serum samples and then diluted 5000-fold with hydrolysis buffer. The diluted samples were detected under optimal conditions. The recoveries of 50, 100, and 150 U L−1 ALP were 93.3%, 100.0%, and 110.0% with RSD ranging from 2.09% to 10.1%, respectively (Table 2). Furthermore, the proposed CL method was also employed for the detection of ALP in real serum samples, the results of which were compared with results obtained from a commercial kit. The concentration of ALP in three serum samples was determined to be 23.2, 18.9, and 23.4 U L−1 by using the commercial kit, while by using the proposed CL method it was determined to be 21.1, 19.4, and 23.9 U L−1, respectively (Table S2, Supporting Information). The above results demonstrated the applicability of the proposed CL system for the detection of ALP in serum samples.

Table 2 The recovery of CL detection of ALP spiked in human serum

Conclusion

In summary, the Fe-BTC after incubating with ascorbic acid was found to enhance the luminol CL reaction. Mechanism studies showed that the incubation of Fe-BTC with ascorbic acid led to the reduction of Fe3+ ions in the 2D Fe-BTC to Fe2+ producing reduced Fe-BTC which acted as the catalyst in the luminol CL reaction. Under optimal conditions, the CL intensity increased linearly with increasing concentrations of ascorbic acid ranging from 5 to 500 nM. Based on the good CL responses of ascorbic acid in the 2D Fe-BTC-luminol CL reaction, a turn-on CL assay for the detection of ALP activity was established using MAP as the substrate. Inherent from the specific hydrolysis of the MAP by ALP to produce ascorbic acid and its specific enhancement effect on the luminol–Fe BTC CL reaction, the proposed turn-on CL assay featured good selectivity and low background. As low as 0.00046 U L−1 of ALP could be sensitively detected. Benefiting from the high detection sensitivity, ALP in serum samples can be detected after a simple dilution process without any other complex pretreatments. We believed that the proposed CL assay has great potential in being applied in biochemistry, pharmaceutical analysis, and clinical diagnosis.